Abstract
Alzheimer's disease (AD) is the major cause of dementia and one of the intractable neurodegenerative diseases. There are many reports that neuroinflammation is related to the pathomechanism of AD and microglia have an important role in neuroinflammation of central nervous system. Galectin-3 is a member of the lectin family and has the function related to proinflammatory processes. Recently, some reports said that serum or cerebrospinal fluid galectin-3 levels were elevated in AD patients. In this study, we developed a novel vaccine to reduce galectin-3 and examined the effect of vaccination using inflammation model of mice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
